Search results
Showing 301 to 315 of 1833 results for carers
In development Reference number: GID-TA11767 Expected publication date: 04 November 2026
Olezarsen for treating familial chylomicronaemia syndrome [ID6585]
In development Reference number: GID-TA11678 Expected publication date: 19 August 2026
In development Reference number: GID-TA11502 Expected publication date: 02 December 2026
In development Reference number: GID-TA10979 Expected publication date: 11 March 2026
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]
In development Reference number: GID-TA11742 Expected publication date: 05 August 2026
Brain tumours (primary) and brain metastases in over 16s (QS203)
This quality standard covers diagnosing, monitoring and managing any type of primary brain tumour or brain metastases in adults (aged 16 or over). It describes high-quality care in priority areas for improvement.
View quality statements for QS203Show all sections
Sections for QS203
- Quality statements
- Quality statement 1: GP direct access to MRI
- Quality statement 2: Named healthcare professional
- Quality statement 3: 5-aminolevulinic acid-guided resection
- Quality statement 4: Risk of late effects of treatment
- Quality statement 5: Neurological rehabilitation
- About this quality standard
In development Reference number: GID-TA11379 Expected publication date: TBC
In development Reference number: GID-TA11140 Expected publication date: TBC
In development Reference number: GID-TA11232 Expected publication date: 08 April 2026
In development Reference number: GID-IPG10216 Expected publication date: 25 February 2026
This quality standard covers decision making in people aged 16 and over, using health and social care services who may lack capacity to make their own decisions (now or in the future). It aims to support implementation of the aims and principles of the Mental Capacity Act 2005 and relevant Codes of Practice. It is not a substitute for these.
In development Reference number: GID-TA11768 Expected publication date: 03 September 2026
In development Reference number: GID-TA11416 Expected publication date: 08 July 2026
This guideline covers how healthcare services for adults with head and neck cancers should be organised. It aims to improve care by recommending which healthcare professionals should be involved and the types of hospital or cancer centre best suited to provide the care.
Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]
In development Reference number: GID-TA10994 Expected publication date: TBC